InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by LAPOINTE ANTHONY GREGG. Officer active across 2 companies, notably Rigel Pharmaceuticals INC. Aggregated, 5 reports have been recorded. History available since 19 May 2021. The latest transaction was filed on 25 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
5 of 5 declarations